This inventor holds 1 USPTO granted patent. Top assignees: Astrazeneca Ab, Nektar Therapeutics. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,531 
1 out of 415 
Years Active: 2015
Title: Innovations of Bengt Aslund in Pharmaceutical Chemistry
Introduction
Bengt Aslund is an accomplished inventor located in Södertälje, Sweden. He is known for his significant contribution to pharmaceutical chemistry, particularly through his innovative patent involving naloxol-polyethylene glycol conjugates. His work has had implications in the development of pharmaceutical compositions, enhancing the efficiency and effectiveness of various treatments.
Latest Patents
Bengt Aslund holds one patent that showcases his inventive prowess: the "Crystalline naloxol-PEG conjugate." This patent details naloxol-polyethylene glycol conjugates in oxalate or phosphate salt forms, including crystalline versions. Furthermore, the patent elaborates on methods for preparing these salt forms and discusses pharmaceutical compositions that incorporate them. The innovation presented in this patent addresses a crucial need in drug formulation.
Career Highlights
Throughout his career, Bengt Aslund has made significant strides while working with prominent companies such as AstraZeneca AB and Nektar Therapeutics. His roles in these organizations have allowed him to develop and refine his expertise in the fields of drug development and pharmaceutical applications. His contributions have not only advanced scientific knowledge but have also played a critical role in the commercialization of new therapeutic solutions.
Collaborations
Bengt has had the opportunity to collaborate with notable colleagues, including Carl-Johan Aurell and Martin Hans Bohlin. Working alongside such skilled professionals has enabled him to enhance his research and innovation capabilities, promoting a strong culture of teamwork and shared goals in advancing pharmaceutical advancements.
Conclusion
In conclusion, Bengt Aslund exemplifies the essence of innovation within pharmaceutical chemistry. His groundbreaking patent work on naloxol-PEG conjugates has the potential to influence future treatments and drug formulations significantly. His collaborations and contributions at well-known firms highlight the importance of teamwork in achieving remarkable advancements in science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile